As of Wednesday close, Vaxart Inc.’s (NASDAQ:VXRT) stock traded at $0.70. The average number of shares traded per day over the past five days has been 1,094,820 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0364 fall in that time frame. In the last twenty days, the average volume was 951,005, while in the previous 50 days, it was 2,187,090.
Since last month, VXRT stock retreated -9.85%. Shares of the company fell to $0.6660 on 08/16/23, the lowest level in the past month. A 52-week high of $4.34 was reached on 05/16/23 after having rallying from a 52-week low of $0.56. Since the beginning of this year, VXRT’s stock price has dropped by -26.82% or -$0.2577, and marked a new high 7 times. However, the stock has declined by -83.80% since its 52-week high.
VXRT stock investors should be aware that Vaxart Inc. (VXRT) stock had its last reported insider trading activity 232 days ago on Dec 28. Watson W. Mark, the Director of the company, purchased of 20,000 shares for $0.76 on Dec 28. It resulted in a $15,140 investment by the insider.
Valuation Metrics
The stock’s beta is 0.68. Besides these, the trailing price-to-sales (P/S) ratio of 52.30, the price-to-book (PB) ratio of 1.15.
Financial Health
In the three months ended June 29, Vaxart Inc.’s quick ratio stood at 5.10, while its current ratio was 5.10, showing that the company is able to pay off its debt. Based on annual data, VXRT earned $114.69 million in gross profit and brought in $0.11 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -97.40%. Return on equity (ROE) for the past 12 months was -99.00%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. VXRT’s revenue rose 100.0% to $0.68 million during the quarter, while net income inched up to $1.36 million. While analysts expected Vaxart Inc. to report -$0.18 quarterly earnings, the actual figure was -$0.16 per share, beating the consensus estimate by 11.10%. During the quarter, the company generated -$21.11 million in EBITDA. The liabilities of Vaxart Inc. were 37.58 million at the end of its most recent quarter ended June 29, and its total debt was $21.0 million. The value of shareholders’ equity is $151.97 million.
Technical Picture
This quick technical analysis looks at Vaxart Inc.’s (VXRT) price momentum. With a historical volatility rate of 50.06%, the RSI 9-day stood at 39.46% on 16 August.
With respect to its five-day moving average, the current Vaxart Inc. price is down by -4.92% percent or -$0.0364. At present, VXRT shares trade -14.21% below its 20-day simple moving average and -6.33% percent below its 100-day simple moving average. However, the stock is currently trading approximately -44.63% below its SMA50 and -57.64% below its SMA200.
Stochastic coefficient K was 24.75% and Stochastic coefficient D was 20.60%, while ATR was 0.0458. Given the Stochastic reading of 24.16% for the 14-day period, the RSI (14) reading has been calculated as 40.50%. As of today, the MACD Oscillator reading stands at -0.0140, while the 14-day reading stands at -0.0349.
Analyst Ratings
Vaxart Inc. (VXRT) has been rated Overweight by analysts. According to 0 brokerage firms, VXRT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Vaxart Inc. stock as buy, with 2 recommending it as overweight.
With a median target price of $4.00, the current consensus forecast for the stock is $1.50 – $8.00. Based on these forecasts, analysts predict Vaxart Inc. (VXRT) will achieve an average price target of $4.50.
